RA Capital Management’s Century Therapeutics IPSC Stock Holding History

RA Capital Management’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$43.5M	Hold	17,754,430	–	–	0.38%	43
2026 Q1	$40.1M	Buy	+17,754,430	New	+$37.3M	0.43%	39
2022 Q3	–	Sell	-756,821	Closed	-$6.36M	–	88
2022 Q2	$6.36M	Sell	756,821 -157,273	-17%	-$1.54M	0.17%	67
2022 Q1	$11.5M	Hold	914,094	–	–	0.25%	72
2021 Q4	$14.5M	Hold	914,094	–	–	0.26%	67
2021 Q3	$23M	Hold	914,094	–	–	0.32%	60
2021 Q2	$26.8M	Buy	+914,094	New	+$23.2M	0.43%	57

Other funds holding IPSC

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

RA Capital Management's IPSC Position: Q2 2026 in Review

RA Capital Management held its Century Therapeutics (IPSC) position steady in Q2 2026 at 17,754,430 shares worth $43.5M. The position accounts for 0.38% of the portfolio, ranked #43.

RA Capital Management first reported a position in IPSC in Q2 2021 and has held it in 7 quarters since. 99 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

RA Capital Management held 17,754,430 shares of Century Therapeutics worth $43.5M as of Q2 2026.
RA Capital Management left its Century Therapeutics share count unchanged in Q2 2026.
Century Therapeutics made up 0.38% of RA Capital Management's portfolio in Q2 2026, its #43 holding.
RA Capital Management first reported a position in Century Therapeutics in Q2 2021 and has held it in 7 quarters since.
99 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on RA Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.